Evidence map›Paper›PMID 28348172›Full record

ArticleMolecular & cellular proteomics : MCP2017

Database-independent Protein Sequencing (DiPS) Enables Full-length

Alon Savidor, Rotem Barzilay, Dalia Elinger, Yosef Yarden, Moshit Lindzen, Alexandra Gabashvili, Ophir Adiv Tal, Yishai Levin

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. A Handle on Mass Coincidence Errors inJournal of proteome research · 2024
    Article
  3. Article
  4. Review
  5. Mass Spectrometry-BasedJournal of proteome research · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alon SavidorFrom ‡The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot.
Rotem BarzilayFrom ‡The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot.
Dalia ElingerFrom ‡The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot.
Yosef Yardenthe §Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel 76100.
Moshit Lindzenthe §Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel 76100.
Alexandra GabashviliFrom ‡The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot.
Ophir Adiv TalFrom ‡The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot.
Yishai LevinFrom ‡The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot; yishai.levin@weizmann.ac.il.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional "bottom-up" proteomic approaches use proteolytic digestion, LC-MS/MS, and database searching to elucidate peptide identities and their parent proteins. Protein sequences absent from the database cannot be identified, and even if present in the database, complete sequence coverage is rarely achieved even for the most abundant proteins in the sample. Thus, sequencing of unknown proteins such as antibodies or constituents of metaproteomes remains a challenging problem. To date, there is no available method for full-length protein sequencing, independent of a reference database, in high throughput. Here, we present Database-independent Protein Sequencing, a method for unambiguous, rapid, database-independent, full-length protein sequencing. The method is a novel combination of non-enzymatic, semi-random cleavage of the protein, LC-MS/MS analysis, peptide

Indexed as

alpha-2-HS-GlycoproteinAntibodiesChromatography, LiquidDatabases, ProteinMyoglobinProteomicsSequence AnalysisSequence Analysis, ProteinSerum Albumin, BovineTandem Mass Spectrometryalpha-2-HS-GlycoproteinAntibodiesMyoglobinSerum Albumin, Bovine

Identifiers

PMID28348172
PMCPMC5461544
OpenAlexW2600587704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.